Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Indonesia Energy Corporation Limited (INDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Indonesia Energy Corporation Limited — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Indonesia Energy Corporation Limited trades at $2.66 (market cap $42.31M). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 200.4× Indonesia Energy Corporation Limited's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Indonesia Energy Corporation Limited for 24 Days on average.
| HNGE | INDO | |
|---|---|---|
Market Cap | $8.48B | $42.31M |
Volume | 879,799 | 193,916 |
Sector | Health | Energy |
52-Week High | $105.14 | $6.74 |
52-Week Low | $31.17 | $2.49 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $8.10B | $37.25M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
INDO trades at $2.75 with minimal daily movement (+0.36%). The stock shows bearish technical signals despite unanimous analyst buy ratings. Fundamentally, the company faces significant challenges with negative profit margins (-152.72% net income margin) and consistent quarterly losses, though recent oil discoveries at the K-29 well provide operational optimism. Cash flow remains dependent on financing activities to offset negative operational cash flow.
While analyst consensus remains bullish with 100% buy ratings, the stock presents high-risk exposure due to persistent unprofitability and negative cash generation. The company's exploration success offers potential upside, but investors face substantial execution risk and financial instability in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →
